Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COX-2 Inhibitor for Urethral Stricture Recurrence
NCT06697106Recruiting
- Sponsor
- New Valley University
- Start
- Nov 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in urethral stricture comparing Meloxicam Group with Placebo Group (2 arms). Primary endpoint: Urethral stricture recurrence at 90 days. Started Nov 2024; status: recruiting.
02
Drugs
meloxicam
03
Conditions
urethral stricture
Beyond the preview
Go deeper on NCT06697106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06697106.